Altimmune's total assets for Q1 2026 were $335.63M, an increase of 19.90% from the previous quarter. ALT total liabilities were $51.64M for the fiscal quarter, a -6.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.